Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Deciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response

Fig. 3

Mutational signatures of HGSOC and EEOC patients. A, six different single nucleotide substitutions were detected in HGSOC and EEOC. B, proportions of somatic mutations in 17 mutation signatures for each patient. C, the contribution of signature 3 in HGSOC patients and EEOC patients. HGSOC, high-grade serous ovarian cancer. EEOC, endometrioid epithelial ovarian cancer. Data in C was shown as ‘Mean with SD’. Statistics in C: unpaired t test

Back to article page